Insider Selling: ICU Medical, Inc. (NASDAQ:ICUI) Director Sells $153,682.92 in Stock

ICU Medical, Inc. (NASDAQ:ICUI) Director David C. Greenberg sold 972 shares of the stock in a transaction that occurred on Wednesday, November 27th. The stock was sold at an average price of $158.11, for a total transaction of $153,682.92. Following the completion of the transaction, the director now owns 5,037 shares in the company, valued at $796,400.07. The trade was a 16.18 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this link.

ICU Medical Price Performance

Shares of ICU Medical stock opened at $163.96 on Friday. The company has a quick ratio of 1.03, a current ratio of 2.29 and a debt-to-equity ratio of 0.75. ICU Medical, Inc. has a 52 week low of $83.26 and a 52 week high of $196.26. The stock’s 50-day simple moving average is $174.85 and its 200-day simple moving average is $146.69. The company has a market capitalization of $4.01 billion, a price-to-earnings ratio of -35.88 and a beta of 0.66.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Russell Investments Group Ltd. raised its position in shares of ICU Medical by 46.4% during the first quarter. Russell Investments Group Ltd. now owns 546 shares of the medical instruments supplier’s stock valued at $59,000 after buying an additional 173 shares during the last quarter. Vanguard Group Inc. increased its holdings in ICU Medical by 0.5% in the 1st quarter. Vanguard Group Inc. now owns 2,452,720 shares of the medical instruments supplier’s stock valued at $263,226,000 after acquiring an additional 11,991 shares during the last quarter. CANADA LIFE ASSURANCE Co lifted its stake in ICU Medical by 1.7% in the 1st quarter. CANADA LIFE ASSURANCE Co now owns 20,505 shares of the medical instruments supplier’s stock worth $2,201,000 after purchasing an additional 343 shares in the last quarter. Jane Street Group LLC boosted its holdings in shares of ICU Medical by 79.7% during the 1st quarter. Jane Street Group LLC now owns 89,852 shares of the medical instruments supplier’s stock valued at $9,643,000 after purchasing an additional 39,839 shares during the last quarter. Finally, Virtu Financial LLC purchased a new position in shares of ICU Medical during the first quarter valued at about $288,000. 96.10% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of equities analysts recently commented on the company. Needham & Company LLC reaffirmed a “hold” rating on shares of ICU Medical in a report on Wednesday, November 13th. Raymond James upped their price target on ICU Medical from $158.00 to $190.00 and gave the stock an “outperform” rating in a research report on Thursday, September 12th. Jefferies Financial Group started coverage on ICU Medical in a research report on Monday, October 14th. They set a “hold” rating and a $183.00 price objective on the stock. KeyCorp boosted their price objective on ICU Medical from $198.00 to $209.00 and gave the company an “overweight” rating in a research note on Wednesday, November 13th. Finally, StockNews.com upgraded shares of ICU Medical from a “hold” rating to a “buy” rating in a research note on Wednesday, November 20th. Two analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $173.00.

ICU Medical Company Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.